Chest radiography is widely used in diagnostic imaging. However, perceptual errors -- especially overlooked but visible abnormalities -- remain common and clinically significant. Current workflows and AI systems provide limited support for detecting such errors after interpretation and often lack meaningful human--AI collaboration. We introduce RADAR (Radiologist--AI Diagnostic Assistance and Review), a post-interpretation companion system. RADAR ingests finalized radiologist annotations and CXR images, then performs regional-level analysis to detect and refer potentially missed abnormal regions. The system supports a "second-look" workflow and offers suggested regions of interest (ROIs) rather than fixed labels to accommodate inter-observer variation. We evaluated RADAR on a simulated perceptual-error dataset derived from de-identified CXR cases, using F1 score and Intersection over Union (IoU) as primary metrics. RADAR achieved a recall of 0.78, precision of 0.44, and an F1 score of 0.56 in detecting missed abnormalities in the simulated perceptual-error dataset. Although precision is moderate, this reduces over-reliance on AI by encouraging radiologist oversight in human--AI collaboration. The median IoU was 0.78, with more than 90% of referrals exceeding 0.5 IoU, indicating accurate regional localization. RADAR effectively complements radiologist judgment, providing valuable post-read support for perceptual-error detection in CXR interpretation. Its flexible ROI suggestions and non-intrusive integration position it as a promising tool in real-world radiology workflows. To facilitate reproducibility and further evaluation, we release a fully open-source web implementation alongside a simulated error dataset. All code, data, demonstration videos, and the application are publicly available at https://github.com/avutukuri01/RADAR.

Inter reader variability and cross site domain shift challenge the automatic segmentation of prostate anatomy using T2 weighted MRI images. This study investigates whether transformer models can retain precision amid such heterogeneity. We compare the performance of UNETR and SwinUNETR in prostate gland segmentation against our previous 3D UNet model [1], based on 546 MRI (T2weighted) volumes annotated by two independent experts. Three training strategies were analyzed: single cohort dataset, 5 fold cross validated mixed cohort, and gland size based dataset. Hyperparameters were tuned by Optuna. The test set, from an independent population of readers, served as the evaluation endpoint (Dice Similarity Coefficient). In single reader training, SwinUNETR achieved an average dice score of 0.816 for Reader#1 and 0.860 for Reader#2, while UNETR scored 0.8 and 0.833 for Readers #1 and #2, respectively, compared to the baseline UNets 0.825 for Reader #1 and 0.851 for Reader #2. SwinUNETR had an average dice score of 0.8583 for Reader#1 and 0.867 for Reader#2 in cross-validated mixed training. For the gland size-based dataset, SwinUNETR achieved an average dice score of 0.902 for Reader#1 subset and 0.894 for Reader#2, using the five-fold mixed training strategy (Reader#1, n=53; Reader#2, n=87) at larger gland size-based subsets, where UNETR performed poorly. Our findings demonstrate that global and shifted-window self-attention effectively reduces label noise and class imbalance sensitivity, resulting in improvements in the Dice score over CNNs by up to five points while maintaining computational efficiency. This contributes to the high robustness of SwinUNETR for clinical deployment.

Explainability features are intended to provide insight into the internal mechanisms of an AI device, but there is a lack of evaluation techniques for assessing the quality of provided explanations. We propose a framework to assess and report explainable AI features. Our evaluation framework for AI explainability is based on four criteria: 1) Consistency quantifies the variability of explanations to similar inputs, 2) Plausibility estimates how close the explanation is to the ground truth, 3) Fidelity assesses the alignment between the explanation and the model internal mechanisms, and 4) Usefulness evaluates the impact on task performance of the explanation. Finally, we developed a scorecard for AI explainability methods that serves as a complete description and evaluation to accompany this type of algorithm. We describe these four criteria and give examples on how they can be evaluated. As a case study, we use Ablation CAM and Eigen CAM to illustrate the evaluation of explanation heatmaps on the detection of breast lesions on synthetic mammographies. The first three criteria are evaluated for clinically-relevant scenarios. Our proposed framework establishes criteria through which the quality of explanations provided by AI models can be evaluated. We intend for our framework to spark a dialogue regarding the value provided by explainability features and help improve the development and evaluation of AI-based medical devices.

Brain metastases are a common complication of systemic cancer, affecting over 20% of patients with primary malignancies. Longitudinal magnetic resonance imaging (MRI) is essential for diagnosing patients, tracking disease progression, assessing therapeutic response, and guiding treatment selection. However, the manual review of longitudinal imaging is time-intensive, especially for patients with multifocal disease. Artificial intelligence (AI) offers opportunities to streamline image evaluation, but developing robust AI models requires comprehensive training data representative of real-world imaging studies. Thus, there is an urgent necessity for a large dataset with heterogeneity in imaging protocols and disease presentation. To address this, we present an open-access dataset of 11,884 longitudinal brain MRI studies from 1,430 patients with clinically confirmed brain metastases, paired with clinical and image metadata. The provided dataset will facilitate the development of AI models to assist in the long-term management of patients with brain metastasis.

Foundation models (FMs), large neural networks pretrained on extensive and diverse datasets, have revolutionized artificial intelligence and shown significant promise in medical imaging by enabling robust performance with limited labeled data. Although numerous surveys have reviewed the application of FM in healthcare care, brain imaging remains underrepresented, despite its critical role in the diagnosis and treatment of neurological diseases using modalities such as MRI, CT, and PET. Existing reviews either marginalize brain imaging or lack depth on the unique challenges and requirements of FM in this domain, such as multimodal data integration, support for diverse clinical tasks, and handling of heterogeneous, fragmented datasets. To address this gap, we present the first comprehensive and curated review of FMs for brain imaging. We systematically analyze 161 brain imaging datasets and 86 FM architectures, providing information on key design choices, training paradigms, and optimizations driving recent advances. Our review highlights the leading models for various brain imaging tasks, summarizes their innovations, and critically examines current limitations and blind spots in the literature. We conclude by outlining future research directions to advance FM applications in brain imaging, with the aim of fostering progress in both clinical and research settings.

Multimodal medical imaging integrates diverse data types, such as structural and functional neuroimaging, to provide complementary insights that enhance deep learning predictions and improve outcomes. This study focuses on a neuroimaging prediction framework based on both structural and functional neuroimaging data. We propose a next-generation prediction model, \textbf{MultiViT2}, which combines a pretrained representative learning base model with a vision transformer backbone for prediction output. Additionally, we developed a data augmentation module based on the latent diffusion model that enriches input data by generating augmented neuroimaging samples, thereby enhancing predictive performance through reduced overfitting and improved generalizability. We show that MultiViT2 significantly outperforms the first-generation model in schizophrenia classification accuracy and demonstrates strong scalability and portability.

Dental diagnosis relies on two primary imaging modalities: panoramic radiographs (PX) providing 2D oral cavity representations, and Cone-Beam Computed Tomography (CBCT) offering detailed 3D anatomical information. While PX images are cost-effective and accessible, their lack of depth information limits diagnostic accuracy. CBCT addresses this but presents drawbacks including higher costs, increased radiation exposure, and limited accessibility. Existing reconstruction models further complicate the process by requiring CBCT flattening or prior dental arch information, often unavailable clinically. We introduce ViT-NeBLa, a vision transformer-based Neural Beer-Lambert model enabling accurate 3D reconstruction directly from single PX. Our key innovations include: (1) enhancing the NeBLa framework with Vision Transformers for improved reconstruction capabilities without requiring CBCT flattening or prior dental arch information, (2) implementing a novel horseshoe-shaped point sampling strategy with non-intersecting rays that eliminates intermediate density aggregation required by existing models due to intersecting rays, reducing sampling point computations by $52 \%$, (3) replacing CNN-based U-Net with a hybrid ViT-CNN architecture for superior global and local feature extraction, and (4) implementing learnable hash positional encoding for better higher-dimensional representation of 3D sample points compared to existing Fourier-based dense positional encoding. Experiments demonstrate that ViT-NeBLa significantly outperforms prior state-of-the-art methods both quantitatively and qualitatively, offering a cost-effective, radiation-efficient alternative for enhanced dental diagnostics.

Three-dimensional (3D) ultrasound (US) aims to provide sonographers with the spatial relationships of anatomical structures, playing a crucial role in clinical diagnosis. Recently, deep-learning-based freehand 3D US has made significant advancements. It reconstructs volumes by estimating transformations between images without external tracking. However, image-only reconstruction poses difficulties in reducing cumulative drift and further improving reconstruction accuracy, particularly in scenarios involving complex motion trajectories. In this context, we propose an enhanced motion network (MoNetV2) to enhance the accuracy and generalizability of reconstruction under diverse scanning velocities and tactics. First, we propose a sensor-based temporal and multi-branch structure that fuses image and motion information from a velocity perspective to improve image-only reconstruction accuracy. Second, we devise an online multi-level consistency constraint that exploits the inherent consistency of scans to handle various scanning velocities and tactics. This constraint exploits both scan-level velocity consistency, path-level appearance consistency, and patch-level motion consistency to supervise inter-frame transformation estimation. Third, we distill an online multi-modal self-supervised strategy that leverages the correlation between network estimation and motion information to further reduce cumulative errors. Extensive experiments clearly demonstrate that MoNetV2 surpasses existing methods in both reconstruction quality and generalizability performance across three large datasets.

Accurate segmentation of vascular structures in coronary angiography remains a core challenge in medical image analysis due to the complexity of elongated, thin, and low-contrast vessels. Classical convolutional neural networks (CNNs) often fail to preserve topological continuity, while recent Vision Transformer (ViT)-based models, although strong in global context modeling, lack precise boundary awareness. In this work, we introduce BAVT, a Boundary-Aware Vision Transformer, a ViT-based architecture enhanced with an edge-aware loss that explicitly guides the segmentation toward fine-grained vascular boundaries. Unlike hybrid transformer-CNN models, BAVT retains a minimal, scalable structure that is fully compatible with large-scale vision foundation model (VFM) pretraining. We validate our approach on the DCA-1 coronary angiography dataset, where BAVT achieves superior performance across medical image segmentation metrics outperforming both CNN and hybrid baselines. These results demonstrate the effectiveness of combining plain ViT encoders with boundary-aware supervision for clinical-grade vascular segmentation.

Risk stratification is a key tool in clinical decision-making, yet current approaches often fail to translate sophisticated survival analysis into actionable clinical criteria. We present a novel method for unsupervised machine learning that directly optimizes for survival heterogeneity across patient clusters through a differentiable adaptation of the multivariate logrank statistic. Unlike most existing methods that rely on proxy metrics, our approach represents novel methodology for training any neural network architecture on any data modality to identify prognostically distinct patient groups. We thoroughly evaluate the method in simulation experiments and demonstrate its utility in practice by applying it to two distinct cancer types: analyzing laboratory parameters from multiple myeloma patients and computed tomography images from non-small cell lung cancer patients, identifying prognostically distinct patient subgroups with significantly different survival outcomes in both cases. Post-hoc explainability analyses uncover clinically meaningful features determining the group assignments which align well with established risk factors and thus lend strong weight to the methods utility. This pan-cancer, model-agnostic approach represents a valuable advancement in clinical risk stratification, enabling the discovery of novel prognostic signatures across diverse data types while providing interpretable results that promise to complement treatment personalization and clinical decision-making in oncology and beyond.